Home
Actavis d.o.o. Belgrade

Actavis d.o.o. Belgrade Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainactavis.rs

Year Founded--

Employees201 - 500

Annual Revenue$5M - $10M

Actavis d.o.o. Belgrade

Actavis d.o.o. Belgrade (including company regionals)

actavis.rs

See more website traffic and engagement information

Actavis d.o.o. Belgrade Revenue up to November 2025 is 5M - 10M

revenue generated by Actavis d.o.o. Belgrade top domains

Actavis d.o.o. Belgrade top domains revenue over 3 years

Revenue for Actavis d.o.o. Belgrade top domains

actavis.rs5M - 10M

See more with Sales Intelligence

Total visits to Actavis d.o.o. Belgrade's top domains

Understand Actavis d.o.o. Belgrade market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

actavis.rs10.7K

See more with Sales Intelligence

Avg. visit duration in Actavis d.o.o. Belgrade's top domains

Analyze Actavis d.o.o. Belgrade engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

actavis.rs00:01:58

See more with Sales Intelligence

Avg. pageviews on Actavis d.o.o. Belgrade's top domains

See how Actavis d.o.o. Belgrade keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

actavis.rs1.98

See more with Sales Intelligence

Actavis d.o.o. Belgrade top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Actavis d.o.o. Belgrade

These are the website technologies, by industry, used by Actavis d.o.o. Belgrade top domains

Conversion & Analytics (4)

Google Analytics

Mobile (2)

Meta Viewport

Social (2)

Facebook Social Plugins

Widget (2)

Google Maps

More Technologies

7

See all

News & Signals from Actavis d.o.o. Belgrade

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTeva Pharmaceutical Industries Ltd. acquired Actavis for $40B on Jan 1st '15.The record high share price was in 2015 after Teva announced the heavily leveraged $40 billion acquisition of Actavis, under then CEO Erez Vigodman.

NewsActavis acquired Duratatherapeutics for $675M on Jun 13th '17.Shortly thereafter, Durata Therapeutics was acquired by Actavis (now Allergan) for $675 million.